CROSSWALK EQ-5D-5L VALUE SET FOR SLOVENIA

被引:9
作者
Prevolnik Rupel, Valentina [1 ]
Ogorevc, Marko [1 ]
机构
[1] Inst Econ Res, Kardeljeva Ploscad 17, Ljubljana 1000, Slovenia
来源
ZDRAVSTVENO VARSTVO | 2020年 / 59卷 / 03期
关键词
EuroQol; EQ-5D-5L; interim value set; health-related quality of life; patientreported outcomes; PSYCHOMETRIC PROPERTIES; HEALTH STATES; POPULATION; EUROQOL; VALUATIONS;
D O I
10.2478/sjph-2020-0024
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Due to the availability of the EQ-5D-5L instrument official translation into Slovenian its use is widespread in Slovenia. However, the health profiles obtained in many studies cannot be ascribed their appropriate values as the EQ-5D-5L value set does not yet exist in Slovenia. Our aim was to estimate an interim EQ-5D-5L value set for Slovenia using the crosswalk methodology developed by the EuroQol Group on the basis of the EQ-5D-3L Slovenian TTO value set. Our secondary aim was to compare the interim values obtained with the EQ-5D-3L Slovenian values. Methods: To obtain a Slovenian interim EQ-5D-5L value set, we applied the crosswalk methodology developed by the EuroQol Group to the Slovenian EQ-5D-3L TTO value set. We examined the differences between values by comparing the mean 3L and 5L value scores and the distribution of values across all respondents. Results: By definition, 3-level and 5-level versions have the same range (from 1 to -0.495) and a health state coded 22222 in the 3-level version corresponds to 33333 in the 5- level version. While the addition of a "slight" severity level (22222) in the 5-level version has a low informational value, the addition of a "severe" health state (44444) covers larger range of the scale. The 5-level version results in fewer health states being valued below 0 and above 0.8. Conclusion: The EQ-5D-5L value set, based on the crosswalk methodology, should be used until a value set for the EQ-5D-5L is derived from preferences elicited directly from a representative sample of the Slovenian general population.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 29 条
[1]  
[Anonymous], 2016, GGPLOT2 ELEGANT GRAP, DOI DOI 10.1007/978-3-319-24277-4
[2]   An EQ-5D-5L value set based on Uruguayan population preferences [J].
Augustovski, Federico ;
Rey-Ares, Lucila ;
Irazola, Vilma ;
Garay, Osvaldo Ulises ;
Gianneo, Oscar ;
Fernandez, Graciela ;
Morales, Marcelo ;
Gibbons, Luz ;
Manuel Ramos-Goni, Juan .
QUALITY OF LIFE RESEARCH, 2016, 25 (02) :323-333
[3]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[4]   A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D [J].
Buchholz, Ines ;
Janssen, Mathieu F. ;
Kohlmann, Thomas ;
Feng, You-Shan .
PHARMACOECONOMICS, 2018, 36 (06) :645-661
[5]   Valuing health-related quality of life: An EQ-5D-5L value set for England [J].
Devlin, Nancy J. ;
Shah, Koonal K. ;
Feng, Yan ;
Mulhern, Brendan ;
van Hout, Ben .
HEALTH ECONOMICS, 2018, 27 (01) :7-22
[6]   EQ-5D and the EuroQol Group: Past, Present and Future [J].
Devlin, Nancy J. ;
Brooks, Richard .
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (02) :127-137
[7]   Modeling valuations for EuroQol health states [J].
Dolan, P .
MEDICAL CARE, 1997, 35 (11) :1095-1108
[8]  
EuroQol organization, EQ 5D 5L CROSSW VAL
[9]   Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe [J].
Golicki, Dominik ;
Jakubczyk, Michal ;
Graczyk, Katarzyna ;
Niewada, Maciej .
PHARMACOECONOMICS, 2019, 37 (09) :1165-1176
[10]  
Golicki Dominik, 2014, Value Health Reg Issues, V4, P19, DOI 10.1016/j.vhri.2014.06.001